SYSBIOGEN

SYSBIOGEN is developing an early diagnosis system for prostate cancer and breast cancer, and a system for monitoring minimal residual disease in blood cancer... SYSBIOGEN aims to apply machine learning-based cancer diagnosis technology and BDA (Blocker Displacement Amplification) application technology to early diagnosis and companion diagnosis of cancer.